TickerFacts.

Biomerica Inc (BMRA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-05-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$5.24M
Year ended 2026-05-31
$730.7K2011-05-31: $15.5K2012-05-31: $685.1K2013-05-31: $730.7K2014-05-31: -$239.6K2015-05-31: -$417.3K2016-05-31: -$594.5K2017-05-31: -$735.4K2018-05-31: -$1.30M2019-05-31: -$2.25M2020-05-31: -$2.61M2021-05-31: -$7.36M2022-05-31: -$4.19M2023-05-31: -$7.14M2024-05-31: -$6.29M2025-05-31: -$5.05M2026-05-31: -$5.24M-$5.24M
2011-05-31 EBITDA (USD) 2026-05-31
Period endedEBITDAChange YoYSource filing
2026-05-31-$5.24Mn/m2026-08-31, From 2025-06-01
2025-05-31-$5.05Mn/m2026-08-31, From 2024-06-01
2024-05-31-$6.29Mn/m2025-08-29, From 2023-06-01
2023-05-31-$7.14Mn/m2024-08-28, From 2022-06-01
2022-05-31-$4.19Mn/m2023-08-25, From 2021-06-01
2021-05-31-$7.36Mn/m2022-08-29, From 2020-06-01
2020-05-31-$2.61Mn/c2021-10-14, From 2019-06-01
2019-05-31-$2.25Mn/m2020-08-31, From 2018-06-01
2018-05-31-$1.30Mn/m2019-08-29, From 2017-06-01
2017-05-31-$735.4Kn/m2018-08-29, From 2016-06-01
2016-05-31-$594.5Kn/m2017-08-29, From 2015-06-01
2015-05-31-$417.3Kn/m2016-08-29, From 2014-06-01
2014-05-31-$239.6Kn/m2015-08-31, From 2013-06-01
2013-05-31$730.7K+6.7%2014-08-29, From 2012-06-01
2012-05-31$685.1Kn/m2013-08-29, From 2011-06-01
2011-05-31$15.5Kn/a2012-08-29, From 2010-06-01

EBITDA at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Biomerica Inc (BMRA)2026-05-31-$5.24Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$48.93Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.80Mn/m
Volitionrx Ltd (VNRX)2025-12-31-$20.75Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$283.99Mn/m
Immucell Corp (ICCC)2025-12-31$4.43M+306.8%
Alpha Teknova, Inc. (TKNO)2025-12-31-$10.63Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$431.22Mn/m
Myriad Genetics Inc (MYGN)2025-12-31-$333.50Mn/m

Compare BMRA, IMDX, AWHL, VNRX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗